| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.52B | $5.28B | $5.35B |
| YoY Revenue Growth % | +23.5% | -1.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.84B | $1.46B | $1.30B |
| Operating Margin % | 28.1% | 27.6% | 24.2% |
| Net Income (GAAP) | $929.5M | $760.4M | $714.3M |
| EBITDA (Normalized) | $4.06B | $3.55B | $1.49B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.36B | $1.78B | $1.94B |
| Capital Expenditures (CapEx) | $2.78B | $2.61B | $240.7M |
| Free Cash Flow (FCF) | -$420.0M | -$832.5M | $1.69B |
| FCF Margin % | -6.4% | -15.8% | 31.7% |
| Return on Invested Capital (ROIC %) | 8.2% | 7.2% | 14.4% |
| Cash & Short-Term Equivalents | $110.1M | $156.6M | — |
| Total Debt (Short + Long Term) | $8.39B | $7.44B | $2.76B |
| Total Stockholders' Equity | $9.45B | $8.68B | $5.67B |